Background Image
Table of Contents Table of Contents
Previous Page  33 / 70 Next Page
Information
Show Menu
Previous Page 33 / 70 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 5, September/October 2016

AFRICA

303

inferior MI group (62.35

±

19.86 ml) (

p

=

0.002 and

p

=

0.028,

respectively) (Fig. 3B). The mean LVESVI in the anterior MI

group (43.74

±

16.11 ml/m

2

) was significantly higher than that in

both the group with no previous MI (30.52

±

12.02 ml/m

2

) and

the posterior/inferior MI group (34.67

±

11.76 ml/m

2

) (

p

=

0.002

and

p

=

0.026, respectively) (Fig. 3B).

The mean LVEF in the anterior MI group (36.90

±

12.21%)

was significantly lower than that in both the group with no

previous MI (51.62

±

10.97%) and the posterior/inferior MI

group (46.00

±

7.54%) (

p

=

0.002 and

p

=

0.024, respectively)

(Fig. 3C). The differences in FS values between the groups were

similar to the differences in EF values (Fig. 3C).

Discussion

The results of this study indicate that (1) the patients who had

suffered an anterior MI had worse LV function than both those

with no previous MI and those with posterior/inferior MI, and

(2) the levels of pro-inflammatory cytokines in the plasma and

pericardial fluid in patients with anterior MI were increased

compared to patients with no previous MI.

Adrenomedullin, a 52-amino acid peptide with structural

homology to calcitonin gene-related peptide, was initially

isolated from human phaeochromocytoma.

11

Adrenomedullin

is synthesised by many mammalian tissues, including the

adrenal medulla, endothelial and vascular smooth muscle cells,

myocardium and central nervous system.

12

Clinical studies suggest that synthesis of adrenomedullin is

up-regulated during myocardial ischaemia. Measurement of

plasma levels of adrenomedullin in patients in the acute stages

of MI showed elevated circulating levels of adrenomedullin

within 24 to 48 hours of admission, which gradually decreased

over a three-week period.

13

On the other hand, Miyao

et al

.

14

reported that in patients with acute MI, increased plasma levels

of adrenomedullin in the very early phase of acute MI returned

to normal limits approximately four weeks later.

In our study, the timespan between MI and CABG was three

weeks or longer. We found that plasma adrenomedullin levels in

both the anterior MI and the posterior/inferior MI groups were

higher than that in the group with no previous MI. In agreement

with the results of Miyao

et al

.,

14

our results suggest that the

elevated adrenomedullin levels were most likely a consequence

of the recent MI.

It is generally considered that pericardial fluid is not merely

an ultra-filtrate of plasma, but also a transudate from the

cardiac interstitium.

15

Adrenomedullin mRNA is expressed by

several cardiovascular tissues, including the cardiomyocytes,

vascular endothelial and smooth muscle cells.

12

Therefore, it can

be assumed that the level of adrenomedullin in pericardial fluid

may increase concomitantly with plasma levels.

Supporting this assumption, increased pericardial fluid

concentrations of adrenomedullin have been reported in patients

with cardiac remodelling.

16

Additionally, adrenomedullin levels

were reported to be slightly higher in the pericardial fluid than

in the plasma in patients undergoing CABG.

17

Consistent with

this report, we also found that adrenomedullin levels in the

pericardial fluid were slightly higher than those in the plasma in

all three groups.

In our study, the anterior MI group had the worst LV function,

as shown by echocardiography. Miyao

et al

. suggested that

adrenomedullin levels in patients with acute MI may indirectly

reflect the extent of ventricular dysfunction.

14

In addition,

LVEDD (mm)

LVEDVI (ml/m

2

)

LVEDV (ml)

No previous MI

Anterior MI

Posterior/inferior

MI

200.00

150.00

100.00

50.00

0.00

*

LVESD (mm)

LVESVI (ml/m

2

)

LVESV (ml)

No previous MI

Anterior MI

Posterior/inferior

MI

120.00

100.00

80.00

60.00

40.00

20.00

0.00

*

*

*

FS (%)

LVEF (%)

No previous MI

Anterior MI

Posterior/inferior

MI

60.00

40.00

20.00

0.00

*

*

Fig. 3.

Results of echocardiographic analyses. A. *

p

<

0.05 for

LVEDD in the anterior MI group vs in the group with

no previous MI. B. *

p

<

0.05 for LVESD, LVESV and

LVESVI in the anterior MI group vs in the other groups.

C. *

p

<

0.05 for FS and LVEF in the anterior MI group

vs in the other groups. LVEDD = left ventricular end-

diastolic diameter, LVEDV = left ventricular end-diastolic

volume, LVEDVI = left ventricular end-diastolic volume

index, LVESD = left ventricular end-systolic diameter,

LVESV = left ventricular end-systolic volume, LVESVI =

left ventricular end-systolic volume index, FS = fraction-

al shortening, LVEF = left ventricular ejection fraction.

A

B

C